Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer (Q43956035)

28 November 2017

title

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer (English)

1 reference

28 November 2017

1 reference

Gilbert Spizzo

1

1 reference

28 November 2017

Peter Obrist

2

1 reference

28 November 2017

Christian Ensinger

3

1 reference

28 November 2017

Igor Theurl

4

1 reference

28 November 2017

Martina Dünser

5

1 reference

28 November 2017

Angela Ramoni

6

1 reference

28 November 2017

Eberhard Gunsilius

7

1 reference

28 November 2017

Günther Eibl

8

1 reference

28 November 2017

Gregor Mikuz

9

1 reference

28 November 2017

Günther Gastl

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

International Journal of Cancer

28 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 November 2017

volume

98

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

883-888

1 reference

Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733

28 November 2017

cites work

1 reference

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

21 January 2018

1 reference

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

21 January 2018

1 reference

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

21 January 2018

1 reference

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients.

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

21 January 2018

1 reference

Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.

21 January 2018

1 reference

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

The biology of the 17-1A antigen (Ep-CAM)

21 January 2018

1 reference

Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins

21 January 2018

1 reference

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

21 January 2018

1 reference

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.

21 January 2018

1 reference

c-erbB-2 gene product associates with catenins in human cancer cells.

21 January 2018

1 reference

The structural analysis of adhesions mediated by Ep-CAM.

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

21 January 2018

1 reference

Ep-CAM overexpression in breast cancer as a predictor of survival

21 January 2018

1 reference

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

21 January 2018

1 reference

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

21 January 2018

1 reference

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

21 January 2018

1 reference

Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue

21 January 2018

1 reference

Markers for assessment of nodal metastasis in laryngeal carcinoma

21 January 2018

1 reference

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

21 January 2018

1 reference

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10270

1 reference

28 November 2017

1 reference